Compounds > chlordiazepoxide

chlordiazepoxide and furosemide

chlordiazepoxide has been researched along with furosemide in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (31.25)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (31.25)	29.6817
2010's	6 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM	1
Lombardo, F; Obach, RS; Waters, NJ	1
Arneric, SP; Bai, S; Clarke, T; Fitzgerald, L; Gilligan, PJ; Grossman, S; Hartig, P; He, L; Heman, K; Krause, C; Lelas, S; Li, YW; Marshall, A; McElroy, JF; Miller, K; Robertson, D; Saye, J; Trainor, G; Ward, K; Wong, H; Zaczek, R; Zeller, K; Zhang, G	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Katayama, I; Masuzawa, M; Nishioka, K; Nishiyama, S; Yokozeki, H	1
Appelt, GD; Reyes, E	1
Austin, TR	1
D'Arcy, PF	1

Reviews

1 review(s) available for chlordiazepoxide and furosemide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

15 other study(ies) available for chlordiazepoxide and furosemide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Molecular characteristics for solid-state limited solubility. Journal of medicinal chemistry, 2008, May-22, Volume: 51, Issue:10 Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists. Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9 Topics: Administration, Oral; Animals; Behavior, Animal; Biological Availability; Clinical Trials as Topic; Dogs; Inhibitory Concentration 50; Rats; Receptors, Corticotropin-Releasing Hormone; Solubility; Structure-Activity Relationship; Triazines; Water	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Drug-induced chronic pigmented purpura. The Journal of dermatology, 1989, Volume: 16, Issue:3 Topics: Aged; Chlordiazepoxide; Chronic Disease; Female; Furosemide; Humans; Male; Middle Aged; Nitroglycerin; Pigmentation Disorders; Purpura; Thiamine	1989
Psychiatric side effects of nonpsychiatric drugs. Seminars in psychiatry, 1971, Volume: 3, Issue:4 Topics: Aminophylline; Analgesics; Anti-Anxiety Agents; Anti-Bacterial Agents; Anticonvulsants; Antiemetics; Antihypertensive Agents; Central Nervous System Stimulants; Chlordiazepoxide; Diazepam; Diuretics; Drug-Related Side Effects and Adverse Reactions; Furosemide; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Insulin; Isoniazid; Mental Disorders; Methyldopa; Phenobarbital; Prednisone	1971
Pharmacological aspects of concurrent administration of furosemide and skeletal muscle relaxants. Journal of pharmaceutical sciences, 1972, Volume: 61, Issue:4 Topics: Animals; Blood Pressure; Chlordiazepoxide; Diaphragm; Diuresis; Drug Combinations; Drug Interactions; Electric Stimulation; Female; Furosemide; Hydrogen-Ion Concentration; Male; Muscles; Neuromuscular Nondepolarizing Agents; Osmolar Concentration; Phrenic Nerve; Potassium; Rats; Sodium; Succinylcholine; Tubocurarine	1972
Mixed drug overdosage with phenelzine, amytal and chlordiazepoxide. A case report. Anaesthesia, 1966, Volume: 21, Issue:2 Topics: Adult; Amobarbital; Chlordiazepoxide; Female; Furosemide; Humans; Methoxamine; Phenelzine	1966
Early reports on drug interactions. Drug intelligence & clinical pharmacy, 1983, Volume: 17, Issue:2 Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine	1983